182 related articles for article (PubMed ID: 33001336)
1. Impact of wait time from neoadjuvant chemotherapy to surgery in breast cancer: Does time to surgery affect patient outcomes? : Time from Neoadjuvant Chemotherapy to Surgery.
Lai V; Hajjaj O; Le D; Shokoohi A; Chia S; Simmons C
Breast Cancer Res Treat; 2020 Dec; 184(3):755-762. PubMed ID: 33001336
[TBL] [Abstract][Full Text] [Related]
2. Impact of Time from Completion of Neoadjuvant Chemotherapy to Surgery on Survival Outcomes in Breast Cancer Patients.
Sanford RA; Lei X; Barcenas CH; Mittendorf EA; Caudle AS; Valero V; Tripathy D; Giordano SH; Chavez-MacGregor M
Ann Surg Oncol; 2016 May; 23(5):1515-21. PubMed ID: 26678405
[TBL] [Abstract][Full Text] [Related]
3. Does the Timing of Surgery after Neoadjuvant Therapy in Breast Cancer Patients Affect the Outcome?
Suleman K; Almalik O; Haque E; Mushtaq A; Badran A; Alsayed A; Ajarim D; Al-Tweigeri T; Jastaniyah N; Elhassan T; Alkhayal W
Oncology; 2020; 98(3):168-173. PubMed ID: 31918425
[TBL] [Abstract][Full Text] [Related]
4. Survival After Breast-Conserving Surgery Compared with that After Mastectomy in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy.
Gwark S; Kim HJ; Kim J; Chung IY; Kim HJ; Ko BS; Lee JW; Son BH; Ahn SH; Lee SB
Ann Surg Oncol; 2023 May; 30(5):2845-2853. PubMed ID: 36577865
[TBL] [Abstract][Full Text] [Related]
5. Time to surgery following neoadjuvant chemotherapy for breast cancer impacts residual cancer burden, recurrence, and survival.
Sutton TL; Schlitt A; Gardiner SK; Johnson N; Garreau JR
J Surg Oncol; 2020 Dec; 122(8):1761-1769. PubMed ID: 33125715
[TBL] [Abstract][Full Text] [Related]
6. The role of postmastectomy radiation therapy after neoadjuvant chemotherapy in clinical stage II-III breast cancer patients with pN0: a multicenter, retrospective study (KROG 12-05).
Shim SJ; Park W; Huh SJ; Choi DH; Shin KH; Lee NK; Suh CO; Keum KC; Kim YB; Ahn SD; Kim SS; Ha SW; Chie EK; Kim K; Shin HS; Kim JH; Lee HS
Int J Radiat Oncol Biol Phys; 2014 Jan; 88(1):65-72. PubMed ID: 24161425
[TBL] [Abstract][Full Text] [Related]
7. Patterns of Recurrence and Predictors of Survival in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy, Surgery, and Radiation.
Keilty D; Nezafat Namini S; Swain M; Maganti M; Cil TD; McCready DR; Cescon DW; Amir E; Fleming R; Mulligan AM; Fyles A; Croke JM; Liu FF; Levin W; Koch CA; Han K
Int J Radiat Oncol Biol Phys; 2020 Nov; 108(3):676-685. PubMed ID: 32407932
[TBL] [Abstract][Full Text] [Related]
8. The impact of postmastectomy and regional nodal radiation after neoadjuvant chemotherapy for clinically lymph node-positive breast cancer: a National Cancer Database (NCDB) analysis.
Rusthoven CG; Rabinovitch RA; Jones BL; Koshy M; Amini A; Yeh N; Jackson MW; Fisher CM
Ann Oncol; 2016 May; 27(5):818-27. PubMed ID: 26861597
[TBL] [Abstract][Full Text] [Related]
9. Oncologic safety of breast-conserving surgery compared to mastectomy in patients receiving neoadjuvant chemotherapy for locally advanced breast cancer.
Cho JH; Park JM; Park HS; Park S; Kim SI; Park BW
J Surg Oncol; 2013 Dec; 108(8):531-6. PubMed ID: 24115142
[TBL] [Abstract][Full Text] [Related]
10. Evaluating the effect of neoadjuvant chemotherapy on surgical outcomes after breast conserving surgery.
Woeste MR; Bhutiani N; Donaldson M; McMasters KM; Ajkay N
J Surg Oncol; 2021 Feb; 123(2):439-445. PubMed ID: 33259649
[TBL] [Abstract][Full Text] [Related]
11. Role of Elective Nodal Irradiation in Patients With ypN0 After Neoadjuvant Chemotherapy Followed by Breast-Conserving Surgery (KROG 16-16).
Cho WK; Park W; Choi DH; Kim YB; Kim JH; Kim SS; Kim K; Kim JH; Ahn SJ; Lee SY; Lee J; Kim SW; Kwon J; Ahn KJ
Clin Breast Cancer; 2019 Feb; 19(1):78-86. PubMed ID: 30241965
[TBL] [Abstract][Full Text] [Related]
12. Is local recurrence higher among patients who downstage to breast conservation after neoadjuvant chemotherapy?
Mamtani A; Sevilimedu V; Le T; Morrow M; Barrio AV
Cancer; 2022 Feb; 128(3):471-478. PubMed ID: 34597420
[TBL] [Abstract][Full Text] [Related]
13. Factors affecting locoregional recurrence in breast cancer patients undergoing surgery following neoadjuvant treatment.
Chou HH; Chung WS; Ding RY; Kuo WL; Yu CC; Tsai HP; Shen SC; Chu CH; Lo YF; Chen SC
BMC Surg; 2021 Mar; 21(1):160. PubMed ID: 33757489
[TBL] [Abstract][Full Text] [Related]
14. Disease-free and overall survival after neoadjuvant chemotherapy in breast cancer: breast-conserving surgery compared to mastectomy in a large single-centre cohort study.
Simons JM; Jacobs JG; Roijers JP; Beek MA; Boonman-de Winter LJM; Rijken AM; Gobardhan PD; Wijsman JH; Tetteroo E; Heijns JB; Yick CY; Luiten EJT
Breast Cancer Res Treat; 2021 Jan; 185(2):441-451. PubMed ID: 33073303
[TBL] [Abstract][Full Text] [Related]
15. [The role of postmastectomy radiotherapy in clinical T1-3N1M0 breast cancer patients with pathological negative lymph nodes after neoadjuvant chemotherapy and mastectomy].
Rong QL; Wang SL; Tang Y; Jin J; Song YW; Wang WH; Liu YP; Fang H; Ren H; Liu XF; Yu ZH; Li YX
Zhonghua Zhong Liu Za Zhi; 2017 Jun; 39(6):445-452. PubMed ID: 28635235
[No Abstract] [Full Text] [Related]
16. Oncological outcome of complete response after neoadjuvant chemotherapy for breast conserving surgery: a systematic review and meta-analysis.
Li X; Dai D; Chen B; Tang H; Wei W
World J Surg Oncol; 2017 Nov; 15(1):210. PubMed ID: 29183336
[TBL] [Abstract][Full Text] [Related]
17. Is regional lymph node irradiation necessary in stage II to III breast cancer patients with negative pathologic node status after neoadjuvant chemotherapy?
Daveau C; Stevens D; Brain E; Berges O; Villette S; Moisson P; Gardner M; De la Lande B; Lasry S; Labib A; Le Scodan R
Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):337-42. PubMed ID: 20171795
[TBL] [Abstract][Full Text] [Related]
18. Lymphovascular invasion can be better than pathologic complete response to predict prognosis in breast cancer treated with neoadjuvant chemotherapy.
Ryu YJ; Kang SJ; Cho JS; Yoon JH; Park MH
Medicine (Baltimore); 2018 Jul; 97(30):e11647. PubMed ID: 30045313
[TBL] [Abstract][Full Text] [Related]
19. Time to surgery among women treated with neoadjuvant systemic therapy and upfront surgery for breast cancer.
Prakash I; Thomas SM; Greenup RA; Plichta JK; Rosenberger LH; Hyslop T; Fayanju OM
Breast Cancer Res Treat; 2021 Apr; 186(2):535-550. PubMed ID: 33206290
[TBL] [Abstract][Full Text] [Related]
20. Local radiotherapy alone following neoadjuvant chemotherapy and surgery in combined clinical stage II and III breast cancer.
White R; Dinneen T; Makris A
Radiat Oncol; 2016 Jul; 11():93. PubMed ID: 27457764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
